<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39324167</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>Health equity in COVID-19 testing among patients of a large national pharmacy chain.</ArticleTitle><Pagination><StartPage>1422914</StartPage><MedlinePgn>1422914</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1422914</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2024.1422914</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Several social determinants of health and other structural factors drive racial and ethnic disparities in COVID-19 risk, morbidity, and mortality. Public-private collaborations with community pharmacies have been successful in expanding access to COVID-19 testing and reaching historically underserved communities. The objectives of this study were to describe individuals who sought testing for COVID-19 at a national community pharmacy chain and to understand potential racial and ethnic inequities in testing access, positivity, and infection with emerging variants of concern.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We conducted a cross-sectional study of individuals aged ≥18 who were tested for COVID-19 (SARS-CoV-2) at a Walgreens pharmacy or Walgreen-affiliated mass testing site between May 1, 2021 and February 28, 2022. Positivity was defined as the proportion of positive tests among all administered tests. A geographically balanced random subset of positive tests underwent whole genome sequencing to identify specific viral variants (alpha, delta, and omicron). Logistic regression estimated odds ratios (ORs) and 95% confidence intervals (CIs) to compare the likelihood of testing positive and testing positive with an emerging variant of concern across race and ethnicity groups.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 18,576,360 tests were analyzed (16.0% tests were positive for COVID-19; 59.5% of tests were from White individuals and 13.1% were from Black individuals). American Indian or Alaska Native (OR = 1.12; 95%CI = 1.10-1.13), Hispanic or Latino (1.20; 95%CI = 1.120, 1.21), and Black (1.12; 95%CI = 1.12, 1.13) individuals were more likely to test positive for COVID-19 compared to White individuals. Non-White individuals were also more likely to test positive for emerging variants of concern (e.g., Black individuals were 3.34 (95%CI = 3.14-3.56) times more likely to test positive for omicron compared to White individuals during the transition period from delta to omicron).</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">Using a national database of testing data, we found racial and ethnic differences in the likelihood of testing positive for COVID-19 and testing positive for emerging viral strains. These results demonstrate the feasibility of public-private collaborations with local pharmacies and pharmacy chains to support pandemic response and reach harder to reach populations with important health services.</AbstractText><CopyrightInformation>Copyright © 2024 Singh, Smith-Ray, Ogunkoya, Shah, Harris, Hayes and Mor.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Tanya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Walgreen Co, Deerfield, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith-Ray</LastName><ForeName>Renae L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Walgreen Co, Deerfield, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogunkoya</LastName><ForeName>Elijah</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Walgreen Co, Deerfield, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Walgreen Co, Deerfield, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>Daniel A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, RI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Gerontology and Healthcare Research, Brown University School of Public Health, Providence, RI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Providence Medical Center Veterans Administration Research Service, Providence, RI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayes</LastName><ForeName>Kaleen N</ForeName><Initials>KN</Initials><AffiliationInfo><Affiliation>Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, RI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Gerontology and Healthcare Research, Brown University School of Public Health, Providence, RI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Providence Medical Center Veterans Administration Research Service, Providence, RI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mor</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, RI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Gerontology and Healthcare Research, Brown University School of Public Health, Providence, RI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Providence Medical Center Veterans Administration Research Service, Providence, RI, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U54 AG063546</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003157" MajorTopicYN="N">Community Pharmacy Services</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="Y">COVID-19 Testing</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005006" MajorTopicYN="N">Ethnicity</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069576" MajorTopicYN="Y">Health Equity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006297" MajorTopicYN="N">Health Services Accessibility</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054625" MajorTopicYN="N">Healthcare Disparities</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">health equity</Keyword><Keyword MajorTopicYN="N">pharmacy</Keyword><Keyword MajorTopicYN="N">testing</Keyword><Keyword MajorTopicYN="N">whole genome sequencing</Keyword></KeywordList><CoiStatement>TS, AS, RLS-R, and EO were employed by the company Walgreen Co. DAH has received consulting fees from the company Sanofi for consulting and research unrelated to the present study. KNH has received grant funding paid directly to Brown University for collaborative research from Insight Therapeutics, Sanofi, and Genentech for research on complex insulin regimens, influenza outbreak control, and influenza vaccination in nursing homes. KNH has also served as a consultant for the Canadian Agency for Drugs and Technologies in Health. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>10</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>4</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39324167</ArticleId><ArticleId IdType="pmc">PMC11423355</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2024.1422914</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tai DB, Sia IG, Doubeni CA, Wieland ML. Disproportionate impact of covid-19 on racial and ethnic minority groups in the United States: a 2021 update. J Racial Ethn Health Disparities. (2021) 9:2334–9. doi: 10.1007/s40615-021-01170-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40615-021-01170-w</ArticleId><ArticleId IdType="pmc">PMC8513546</ArticleId><ArticleId IdType="pubmed">34647273</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanijahani A, Iezadi S, Gholipour K, Azami-Aghdash S, Naghibi D. A systematic review of racial/ethnic and socioeconomic disparities in covid-19. Int J Equity Health. (2021) 20:248. doi: 10.1186/s12939-021-01582-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12939-021-01582-4</ArticleId><ArticleId IdType="pmc">PMC8611382</ArticleId><ArticleId IdType="pubmed">34819081</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor CA, Whitaker M, Anglin O, Milucky J, Patel K, Pham H, et al. . COVID-19–associated hospitalizations among adults during SARS-CoV-2 Delta and omicron variant predominance, by race/ethnicity and vaccination status—COVID-NET, 14 states, July 2021–January 2022. MMWR Morb Mortal Wkly Rep. (2022) 71:466–73. doi: 10.15585/mmwr.mm7112e2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7112e2</ArticleId><ArticleId IdType="pmc">PMC8956338</ArticleId><ArticleId IdType="pubmed">35324880</ArticleId></ArticleIdList></Reference><Reference><Citation>Shortreed SM, Gray R, Akosile MA, Walker RL, Fuller S, Temposky L, et al. . Increased covid-19 infection risk drives racial and ethnic disparities in severe COVID-19 outcomes. J Racial Ethn Health Disparities. (2022) 10:149–59. doi: 10.1007/s40615-021-01205-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40615-021-01205-2</ArticleId><ArticleId IdType="pmc">PMC8785693</ArticleId><ArticleId IdType="pubmed">35072944</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko JY, Pham H, Anglin O, Chai SJ, Alden NB, Meek J, et al. . Vaccination status and trends in adult coronavirus disease 2019–associated hospitalizations by race and ethnicity: March 2020–August 2022. Clin Infect Dis. (2023) 77:827–38. doi: 10.1093/cid/ciad266, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciad266</ArticleId><ArticleId IdType="pmc">PMC11019819</ArticleId><ArticleId IdType="pubmed">37132204</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassett MT, Chen JT, Krieger N. Variation in racial/ethnic disparities in covid-19 mortality by age in the United States: a cross-sectional study. PLoS Med. (2020) 17:e1003402. doi: 10.1371/journal.pmed.1003402, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003402</ArticleId><ArticleId IdType="pmc">PMC7575091</ArticleId><ArticleId IdType="pubmed">33079941</ArticleId></ArticleIdList></Reference><Reference><Citation>Khazanchi R, Evans CT, Marcelin JR. Racism, not race, drives inequity across the COVID-19 continuum. JAMA Netw Open. (2020) 3:e2019933. doi: 10.1001/jamanetworkopen.2020.19933, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.19933</ArticleId><ArticleId IdType="pubmed">32975568</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel M, Critchfield-Jain I, Boykin M, Owens A, Nunn T, Muratore R. Actual racial/ethnic disparities in covid-19 mortality for the non-hispanic black compared to non-Hispanic white population in 353 US counties and their association with structural racism. J Racial Ethn Health Disparities. (2021) 9:1697–725. doi: 10.1007/s40615-021-01109-1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40615-021-01109-1</ArticleId><ArticleId IdType="pmc">PMC8404537</ArticleId><ArticleId IdType="pubmed">34462902</ArticleId></ArticleIdList></Reference><Reference><Citation>Berenbrok LA, Tang S, Gabriel N, Guo J, Sharareh N, Patel N, et al. . Access to community pharmacies: a nationwide geographic information systems cross-sectional analysis. J Am Pharm Assoc. (2022) 62:1816–1822.e2. doi: 10.1016/j.japh.2022.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.japh.2022.07.003</ArticleId><ArticleId IdType="pubmed">35965233</ArticleId></ArticleIdList></Reference><Reference><Citation>About the ICATT Program
Centers for Disease Control and Prevention;  (2024) Available at: https://www.cdc.gov/icatt/AboutICATT.html.</Citation></Reference><Reference><Citation>Mullachery PH, Li R, Melly S, Kolker J, Barber S, Diez Roux AV, et al. . Inequities in spatial accessibility to COVID-19 testing in 30 large US cities. Soc Sci Med. (2022) 310:115307. doi: 10.1016/j.socscimed.2022.115307, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2022.115307</ArticleId><ArticleId IdType="pmc">PMC9420026</ArticleId><ArticleId IdType="pubmed">36049353</ArticleId></ArticleIdList></Reference><Reference><Citation>Malden DE, Bruxvoort KJ, Tseng HF, Ackerson B, Choi SK, Florea A, et al. . Distribution of SARS-CoV-2 variants in a large integrated health care system—California, March–July 2021. MMWR Morb Mortal Wkly Rep. (2021) 70:1415–9. doi: 10.15585/mmwr.mm7040a4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7040a4</ArticleId><ArticleId IdType="pmc">PMC8519275</ArticleId><ArticleId IdType="pubmed">34618801</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Census Bureau . American community survey 2016–2020 5-year data release. (2022). Available at: https://www.census.gov/newsroom/press-kits/2021/acs-5-year.html</Citation></Reference><Reference><Citation>Seto E, Min E, Ingram C, Cummings B, Farquhar SA. Community-level factors associated with COVID-19 cases and testing equity in King County, Washington. Int J Environ Res Public Health. (2020) 17:9516. doi: 10.3390/ijerph17249516</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17249516</ArticleId><ArticleId IdType="pmc">PMC7767300</ArticleId><ArticleId IdType="pubmed">33353095</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilal U, Jemmott JB, Schnake-Mahl A, Murphy K, Momplaisir F. Racial/ethnic and neighborhood social vulnerability disparities in covid-19 testing positivity, hospitalization, and in-hospital mortality in a large hospital system in Pennsylvania: a prospective study of electronic health records. Lancet Reg Health. (2022) 10:100220. doi: 10.1016/j.lana.2022.100220</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lana.2022.100220</ArticleId><ArticleId IdType="pmc">PMC8891851</ArticleId><ArticleId IdType="pubmed">35262038</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C-H, Saal A, McGuire DC, Chan PA. Persistently high SARS-CoV-2 positivity rate and incidence for Hispanic/Latinos during state reopening in an urban setting: a retrospective cohort study. Epidemiol Infect. (2021) 149:149. doi: 10.1017/s0950268821000133</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s0950268821000133</ArticleId><ArticleId IdType="pmc">PMC7844162</ArticleId><ArticleId IdType="pubmed">33455608</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention . Risk for COVID-19 infection, hospitalization, and death by race/ethnicity (2023). Available at: https://archive.cdc.gov/www_cdc_gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-race-ethnicity.html (Accessed July 2024).</Citation></Reference><Reference><Citation>Duong KNC, Le LM, Veettil SK, Saidoung P, Wannaadisai W, Nelson RE, et al. . Disparities in COVID-19 related outcomes in the United States by race and ethnicity pre-vaccination era: an umbrella review of meta-analyses. Front Public Health. (2023) 11:1206988. doi: 10.3389/fpubh.2023.1206988, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1206988</ArticleId><ArticleId IdType="pmc">PMC10513444</ArticleId><ArticleId IdType="pubmed">37744476</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosla S, Del Rios M, Chisolm-Straker M, Bilal S, Jang TB, Wang H, et al. . Pandemic phase-related racial and ethnic disparities in COVID-19 positivity and outcomes among patients presenting to emergency departments during the first two pandemic waves in the USA. Emerg Med J. (2024) 41:201–9. doi: 10.1136/emermed-2023-213101, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emermed-2023-213101</ArticleId><ArticleId IdType="pubmed">38429072</ArticleId></ArticleIdList></Reference><Reference><Citation>Langlete P, Tesli M, Veneti L, Starrfelt J, Elstrøm P, Meijerink H. Estimated vaccine effectiveness against SARS-CoV-2 Delta and omicron infections among health care workers and the general adult population in Norway, August 2021 - January 2022. Vaccine. (2023) 41:3923–9. doi: 10.1016/j.vaccine.2023.05.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.05.022</ArticleId><ArticleId IdType="pmc">PMC10169571</ArticleId><ArticleId IdType="pubmed">37211454</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes KH, Harris DA, Zullo AR, Chachlani P, Wen KJ, Smith-Ray RL, et al. . Racial and ethnic disparities in COVID-19 booster vaccination among U.S. older adults differ by geographic region and Medicare enrollment. Front Public Health. (2023) 11:1243958. doi: 10.3389/fpubh.2023.1243958, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1243958</ArticleId><ArticleId IdType="pmc">PMC10456997</ArticleId><ArticleId IdType="pubmed">37637796</ArticleId></ArticleIdList></Reference><Reference><Citation>Khazanchi R, Strumpf A, Essien UR, Powers SD, McManus KA. Geographic accessibility of COVID-19 test to treat sites by race, ethnicity, age, and rurality. JAMA Netw Open. (2022) 5:e2241144. doi: 10.1001/jamanetworkopen.2022.41144, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.41144</ArticleId><ArticleId IdType="pmc">PMC9647480</ArticleId><ArticleId IdType="pubmed">36350654</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan MM, Odoi A, Odoi EW. Geographic disparities in COVID-19 testing and outcomes in Florida. BMC Public Health. (2023) 23:79. doi: 10.1186/s12889-022-14450-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-022-14450-9</ArticleId><ArticleId IdType="pmc">PMC9832260</ArticleId><ArticleId IdType="pubmed">36631768</ArticleId></ArticleIdList></Reference><Reference><Citation>Rader B, Gertz A, Iuliano AD, Gilmer M, Wronski L, Astley CM, et al. . Use of at-home COVID-19 tests—United States, August 23, 2021–March 12, 2022. MMWR Morb Mortal Wkly Rep. (2022) 71:489–94. doi: 10.15585/mmwr.mm7113e1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7113e1</ArticleId><ArticleId IdType="pmc">PMC8979595</ArticleId><ArticleId IdType="pubmed">35358168</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>